Abstract
The study aims to comprehensively assess the profiles of myositis-specific autoantibodies (MSAs) in Chinese patients with polymyositis (PM)/dermatomyositis (DM) and compare them with a Japanese cohort. One hundred forty-five Chinese patients (68 classic DM, 25 clinically amyopathic DM [CADM], and 52 PM) and 165 Japanese patients (56 classic DM, 52 CADM, and 57 PM) were recruited. MSAs were measured with immunoprecipitation, enzyme-linked immunosorbent assay, or immunoprecipitation–immunoblotting. MSA frequencies were compared. The overall frequency of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies was significantly higher in the Chinese patients than in the Japanese cohort (36.6 % [53/145] versus 15.8 % [26/165], respectively, P < 0.001), whereas the frequencies of anti-signal recognition particle (SRP) antibodies (1.4 % [2/145] versus 7.9 % [13/165], respectively, P = 0.008) and anti-aminoacyl-transfer RNA synthetase (anti-ARS) antibodies (27.6 % [40/145] versus 40 % [66/165], respectively, P = 0.02,) were significantly lower. The significantly lower frequency of anti-ARS antibodies and significantly higher frequency of anti-MDA5 antibodies in the Chinese patients were observed in the classic DM subset (14.7 % [10/68] versus 46.4 % [26/56], respectively, P < 0.001, and 45.6 % [31/68] versus 5.4 % [3/56], respectively, P < 0.001) and CADM subset (8.0 % [2/25] versus 28.8 % [15/52], respectively, P = 0.04, and 88.0 % [22/25] versus 44.2 % [23/52], respectively, P = 0.0002), but not in the PM subset. The first detailed profile of MSAs in Chinese patients with PM/DM was established. The differences in MSA frequencies in the Chinese cohort and Japanese cohort suggest underlying genetic and/or environmental differences between these two populations.
Key Messages
• A significantly higher frequency of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies was observed in Chinese patients with polymyositis/dermatomyositis (PM/DM) than in Japanese patients.
• Our findings suggest that distinct genetic and/or local environmental factors affect Chinese and Japanese patients with PM/DM, who have been considered a “homogeneous” population in previous studies.
Similar content being viewed by others
References
Mammen AL (2010) Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 1184:134–153. doi:10.1111/j.1749-6632.2009.05119.x
Sontheimer RD (2010) Clinically amyopathic dermatomyositis: what can we now tell our patients? Arch Dermatol 146(1):76–80. doi:10.1001/archdermatol.2009.323
Mimori T, Imura Y, Nakashima R, Yoshifuji H (2007) Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 19(6):523–529. doi:10.1097/BOR.0b013e3282f01a8c
Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive ILD. Arthritis Rheum 60:2193–2200. doi:10.1002/art.24621
Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, Sun L (2013) Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res 65(8):1316–1324. doi:10.1002/acr.21985
Sato S, Kuwana M (2010) Clinically amyopathic dermatomyositis. Curr Opin Rheumatol 22:639–643. doi:10.1097/BOR.0b013e32833f1987
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824. doi:10.1164/rccm.2009-040GL
Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z (2011) Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol 38(10):973–979. doi:10.1111/j.1346-8138.2011.01262.x
Kang EH, Kuwana M, Okazaki Y, Lee EY, Lee YJ, Lee EB, Song YW (2014) Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients. Mod Rheumatol Jpn Rheum Assoc 24(6):945–948. doi:10.3109/14397595.2014.896494
Labrador-Horrillo M, Martinez MA, Selva-O'Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, Juárez C (2014) Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res 2014:8. doi:10.1155/2014/290797
Chinoy H, Lamb JA, Ollier WE, Cooper RG (2011) Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther 13(3):216. doi:10.1186/ar3327
Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD (1996) Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 39(9):1507–1518
Furuya T, Hakoda M, Tsuchiya N, Kotake S, Ichikawa N, Nanke Y, Nakajima A, Takeuchi M, Nishinarita M, Kondo H, Kawasaki A, Kobayashi S, Mimori T, Tokunaga K, Kamatani N (2004) Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol 31(9):1768–1774
Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K, Ichida H, Katsumata Y, Hanaoka M, Ota Y, Yamanaka H (2012) Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum 64(11):3736–3740. doi:10.1002/art.34657
Nakajima F, Nakamura J, Yokoda T (2001) HLA haplotype distribution of Japanese. MHC 8(1):1–32 (in Japanese)
Qin Qin P, Su F, Xiao Yan W, Xing Z, Meng P, Chengya W, Jie S (2011) Distribution of human leucocyte antigen-A, -B and -DR alleles and haplotypes at high resolution in the population from Jiangsu province of China. Int J Immunogenet 38(6):475–481. doi:10.1111/j.1744-313X.2011.01029.x
Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitany A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71(6):961–965. doi:10.1136/annrheumdis-2011-200182
Muro Y, Sugiura K, Hoshino K, Akiyama M, Tamakoshi K (2011) Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res Ther 13(6):R214. doi:10.1186/ar3547
Acknowledgments
We thank Yuka Okazaki for her excellent technical assistance. This study was supported, in part, by the Nanjing Medical Science and Technique Development Foundation (Z.C.), the National Natural Science Foundation of China (Z.C., no. 81302556), and the Jiangsu Province Kejiao Xingwei Program Foundation (L.S.), and a research grant for intractable diseases from the Japanese Ministry of Health, Labour, and Welfare (M.K.).
Competing interests
MK holds a patent for an anti-MDA5-antibody-measuring kit.
Author contributions
Z.C., W.H., Y.W., and Z.G. collected the samples and clinical data. Z.C. and M.K. performed the analyses and drafted the manuscript. M.K. and L.S. oversaw the whole project and helped to prepare the manuscript. All authors read and approved the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Chen, Z., Hu, W., Wang, Y. et al. Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis. Clin Rheumatol 34, 1627–1631 (2015). https://doi.org/10.1007/s10067-015-2935-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-2935-9